Embecta CORP Schedule 13G passive stakes

American Century Investment Management, Inc., along with its parent entities, has filed a Schedule 13G for Embecta Corp., reporting a minimal beneficial ownership of common stock.

BlackRock, Inc. has reported a beneficial ownership of 7.7% in Embecta Corp's common stock as of June 30, 2026.

River Road Asset Management, LLC has filed an amendment to its Schedule 13G, reporting zero beneficial ownership of Embecta Corp. common stock as of May 26, 2026.

Yacktman Asset Management LP and AMG Yacktman Fund report a combined beneficial ownership of 6.2% of Embecta Corp. common stock as of March 31, 2026.

American Century Investment Management and affiliated entities have reported a 5.8% beneficial ownership stake in Embecta Corp. common stock.

Vanguard Capital Management has filed a Schedule 13G reporting a 5.07% beneficial ownership stake in Embecta Corp.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Embecta Corp common stock following an internal realignment effective January 12, 2026.

The Vanguard Group updated its beneficial ownership in Embecta Corp, reporting a 7.79% stake and detailing an internal realignment affecting its portfolio management services.

American Century Capital Portfolios, American Century Investment Management, American Century Companies, and Stowers Institute for Medical Research have updated their beneficial ownership in Embecta Corp. common stock.

The Vanguard Group has reported a significant beneficial ownership stake of 9.35% in Embecta Corp's common stock, totaling over 5.4 million shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in Embecta Corp.'s common stock as of June 30, 2025.

American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have filed an amended Schedule 13G disclosing their beneficial ownership in Embecta Corp. common stock as of March 31, 2025.

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have jointly filed an amendment to their Schedule 13G, disclosing a 4.66% passive ownership stake in Embecta Corp. as of March 31, 2025.